Role of antibodies to human papillomavirus 16 in prostate cancer: A seroscreening by peptide microarray
Evidence is accumulating in estimating the potential role of human papillomavirus infection in prostate carcinogenesis. However, the results remain inconclusive. We measured the serostatus of antibodies to one of the high-risk human papillomaviruses, human papillomavirus 16, with a newly developed p...
Main Authors: | Xiaojun Zhao, Zheng Zhou, Ye Chen, Wen Chen, Hongwei Ma, Jinxian Pu |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017-05-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317698371 |
Similar Items
-
Chagas disease in the Bolivian Chaco: Persistent transmission indicated by childhood seroscreening study
by: Thomas Hopkins, et al.
Published: (2019-09-01) -
Unreliability of three commercial Coxiella burnetii phase II IgM ELISA kits for the seroscreening of acute Q fever in human cases
by: Selvaraj Stephen, et al.
Published: (2017-01-01) -
Prevalence of antibodies against a cyclic peptide mimicking the FG loop of the human papillomavirus type 16 capsid among Tunisian women
by: Elham Hassen, et al.
Published: (2020-07-01) -
Current applications of antibody microarrays
by: Ziqing Chen, et al.
Published: (2018-02-01) -
Molecular detection of Human Papillomavirus genotype-16&-18 in tissues from patients with prostate cancer and benign prostatic hyperplasia
by: Taghreed F. AL-Mahbobi, et al.
Published: (2011-07-01)